- Investing Ideas
- /
- Hong Kong Big Pharma, Big Dividends
Hong Kong Big Pharma, Big Dividends
Results
5
Large pharmaceutical stocks to buy with strong dividend features.
5 companies
CSPC Pharmaceutical Group
Market Cap: HK$103.9b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.09
7D
7.8%
1Y
103.8%
Sino Biopharmaceutical
Market Cap: HK$121.2b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$6.78
7D
9.7%
1Y
127.5%
China Medical System Holdings
Market Cap: HK$33.8b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.97
7D
8.3%
1Y
92.7%
China Resources Pharmaceutical Group
Market Cap: HK$29.0b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.62
7D
3.8%
1Y
-14.1%
Grand Pharmaceutical Group
Market Cap: HK$27.7b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$7.90
7D
0.6%
1Y
77.5%